» Articles » PMID: 19435850

Diabetes Increases Brain Damage Caused by Severe Hypoglycemia

Overview
Date 2009 May 14
PMID 19435850
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-induced severe hypoglycemia causes brain damage. The hypothesis to be tested was that diabetes portends to more extensive brain tissue damage following an episode of severe hypoglycemia. Nine-week-old male streptozotocin-diabetic (DIAB; n = 10) or vehicle-injected control (CONT; n = 7) Sprague-Dawley rats were subjected to hyperinsulinemic (0.2 U.kg(-1).min(-1)) severe hypoglycemic (10-15 mg/dl) clamps while awake and unrestrained. Groups were precisely matched for depth and duration (1 h) of severe hypoglycemia (CONT 11 +/- 0.5 and DIAB 12 +/- 0.2 mg/dl, P = not significant). During severe hypoglycemia, an equal number of episodes of seizure-like activity were noted in both groups. One week later, histological analysis demonstrated extensive neuronal damage in regions of the hippocampus, especially in the dentate gyrus and CA1 regions and less so in the CA3 region (P < 0.05), although total hippocampal damage was not different between groups. However, in the cortex, DIAB rats had significantly (2.3-fold) more dead neurons than CONT rats (P < 0.05). There was a strong correlation between neuronal damage and the occurrence of seizure-like activity (r(2) > 0.9). Separate studies conducted in groups of diabetic (n = 5) and nondiabetic (n = 5) rats not exposed to severe hypoglycemia showed no brain damage. In summary, under the conditions studied, severe hypoglycemia causes brain damage in the cortex and regions within the hippocampus, and the extent of damage is closely correlated to the presence of seizure-like activity in nonanesthetized rats. It is concluded that, in response to insulin-induced severe hypoglycemia, diabetes uniquely increases the vulnerability of specific brain areas to neuronal damage.

Citing Articles

Exploring the Biological Effects of Anti-Diabetic Vanadium Compounds in the Liver, Heart and Brain.

Dayanand Y, Pather R, Xulu N, Booysen I, Sibiya N, Khathi A Diabetes Metab Syndr Obes. 2024; 17:3267-3278.

PMID: 39247428 PMC: 11380877. DOI: 10.2147/DMSO.S417700.


Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review.

Gholami M, Coleman-Fuller N, Salehirad M, Darbeheshti S, Motaghinejad M Int J Prev Med. 2024; 15:28.

PMID: 39239308 PMC: 11376549. DOI: 10.4103/ijpvm.ijpvm_5_23.


Effect of recurrent severe insulin-induced hypoglycemia on the cognitive function and brain oxidative status in the rats.

Nikpendar M, Javanbakht M, Moosavian H, Sajjadi S, Nilipour Y, Moosavian T Diabetol Metab Syndr. 2024; 16(1):161.

PMID: 39004753 PMC: 11247731. DOI: 10.1186/s13098-024-01410-z.


Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon.

Ali N, Al-Kuraishy H, Al-Gareeb A, Hadi N, Assiri A, Alrouji M Cell Mol Neurobiol. 2024; 44(1):55.

PMID: 38977507 PMC: 11230952. DOI: 10.1007/s10571-024-01489-y.


SARS-CoV-2 Spike Protein Enhances Carboxypeptidase Activity of Angiotensin-Converting Enzyme 2.

Mendiola-Salazar X, Munguia-Laguna M, Franco M, Cano-Martinez A, Santamaria Sosa J, Bautista-Perez R Int J Mol Sci. 2024; 25(11).

PMID: 38892464 PMC: 11172802. DOI: 10.3390/ijms25116276.


References
1.
Canal C, McNay E, Gold P . Increases in extracellular fluid glucose levels in the rat hippocampus following an anesthetic dose of pentobarbital or ketamine-xylazine: an in vivo microdialysis study. Physiol Behav. 2005; 84(2):245-50. DOI: 10.1016/j.physbeh.2004.11.009. View

2.
Simpson I, Appel N, Hokari M, Oki J, Holman G, Maher F . Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem. 1999; 72(1):238-47. DOI: 10.1046/j.1471-4159.1999.0720238.x. View

3.
Perantie D, Wu J, Koller J, Lim A, Warren S, Black K . Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care. 2007; 30(9):2331-7. DOI: 10.2337/dc07-0351. View

4.
Auer R, Hugh J, Cosgrove E, Curry B . Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol. 1989; 8(2):63-8. View

5.
Baird T, Parsons M, Phan T, Phanh T, Butcher K, Desmond P . Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003; 34(9):2208-14. DOI: 10.1161/01.STR.0000085087.41330.FF. View